These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34128309)

  • 21. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients.
    Yu JH; Dong JT; Jia YQ; Jiang NG; Zeng TT; Xu H; Mo XM; Meng WT
    Chin J Cancer; 2013 Apr; 32(4):213-23. PubMed ID: 22776235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
    Lin P; Jones D; Dorfman DM; Medeiros LJ
    Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
    Cheng J; Klairmont MM; Choi JK
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
    DiGiuseppe JA; Wood BL
    Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML.
    Das N; Gupta R; Gupta SK; Bakhshi S; Malhotra A; Rai S; Singh S; Prajapati VK; Sahoo RK; Gogia A; Sharma A; Kumar L
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e673-e684. PubMed ID: 32561191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
    Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig WD
    Ann Hematol; 1998 Sep; 77(3):107-14. PubMed ID: 9797079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia].
    Quijano SM; Torres MM; Vásquez LE; Cuéllar GE; Romero ML; Martín EL; Linares A; Castaño S; Sarmiento IC; Cabrera E; Uribe GI; Andrade RE; Saavedra CE
    Biomedica; 2013; 33(3):468-86. PubMed ID: 24652183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
    Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
    Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib.
    Morishita T; Hayakawa F; Sugimoto K; Iwase M; Yamamoto H; Hirano D; Kojima Y; Imoto N; Naoe T; Kiyoi H
    Oncotarget; 2016 Aug; 7(35):56241-56252. PubMed ID: 27494842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods.
    Øbro NF; Ryder LP; Madsen HO; Andersen MK; Lausen B; Hasle H; Schmiegelow K; Marquart HV
    Haematologica; 2012 Jan; 97(1):137-41. PubMed ID: 21933850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome.
    Asgarian Omran H; Shabani M; Shahrestani T; Sarafnejad A; Khoshnoodi J; Vossough P; Faranoush M; Sharifian RA; Jeddi-Tehrani M; Rabbani H; Shokri F
    Iran J Immunol; 2007 Mar; 4(1):15-25. PubMed ID: 17652839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
    Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype.
    Demina I; Zerkalenkova E; Illarionova O; Olshanskaya Y; Verzhbitskaya T; Semchenkova A; Tsaur G; Rusanova E; Belogurova M; Baidun L; Plyasunova S; Konyuhova T; Kazakova A; Fechina L; Novichkova G; Samochatova E; Myakova N; Maschan A; Popov AM
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2803-2811. PubMed ID: 31463716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways.
    Uzozie AC; Ergin EK; Rolf N; Tsui J; Lorentzian A; Weng SSH; Nierves L; Smith TG; Lim CJ; Maxwell CA; Reid GSD; Lange PF
    J Exp Clin Cancer Res; 2021 Mar; 40(1):96. PubMed ID: 33722259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
    Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
    Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.